FTHFX
Price
$57.43
Change
+$0.28 (+0.49%)
Updated
Jun 22 closing price
Net Assets
11.18B
SSQSX
Price
$16.48
Change
+$0.02 (+0.12%)
Updated
Jun 22 closing price
Net Assets
525.08M
Interact to see
Advertisement

FTHFX vs SSQSX

FTHFX vs SSQSX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. SSQSX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Hold and SSQSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 11.2B vs. SSQSX (525M). FTHFX pays higher dividends than SSQSX: FTHFX (0.59) vs SSQSX (0.19). FTHFX was incepted earlier than SSQSX: FTHFX (15 years) vs SSQSX (21 years). SSQSX (1.16) is less costly to investors than FTHFX (0.64). SSQSX is a more actively managed with annual turnover of: 45.00 vs. FTHFX (28.00). FTHFX has a lower initial minimum investment than SSQSX: FTHFX (1000000) vs SSQSX (10000000). FTHFX annual gain was more profitable for investors over the last year : 30.99 vs. SSQSX (1.75). FTHFX return over 5 years is better than : 61.64 vs. SSQSX (-25.67).
FTHFXSSQSXFTHFX / SSQSX
Total Expense Ratio0.641.0064%
Annual Report Gross Expense Ratio0.641.1655%
Fund Existence15 years21 years-
Gain YTD12.92211.973108%
Front LoadN/AN/A-
Min. Initial Investment10000001000000010%
Min. Initial Investment IRAN/AN/A-
Net Assets11.2B525M2,133%
Annual Yield % from dividends0.590.19306%
Returns for 1 year30.991.751,769%
Returns for 3 years61.63-0.86-7,154%
Returns for 5 years61.64-25.67-240%
Returns for 10 years248.412.1611,516%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LILAK5.300.51
+10.65%
Liberty Latin America Ltd
HPE48.400.99
+2.09%
Hewlett Packard Enterprise Company
MTH75.08-0.65
-0.86%
Meritage Homes Corporation
LAW3.40-0.07
-2.02%
CS Disco
ATOS1.83-0.18
-8.96%
Atossa Therapeutics Inc.